Visual signs and symptoms of multiple system atrophy

References

• Armstrong RA. Visual signs and symptoms of Parkinson's disease. Clin Exp Optom 2008; 91: 129–138.
   PubMed Web of Science ®Google Scholar
• Armstrong RA. Visual signs and symptoms of progressive supranuclear palsy. Clin Exp Optom 2011; 95: 150–160.
   Google Scholar
• Armstrong RA. Visual signs and symptoms of dementia with Lewy bodies: Clin Exp Optom 2012; 94: 621–630.
   Google Scholar
• Armstrong RA, Cairns NJ, Lantos PL. A quantitative study of the pathological lesions in neocortex and hippocampus of 12 patients with corticobasal degeneration. Exp Neurol 2000; 163: 348–356.
   PubMed Web of Science ®Google Scholar
• Probst‐cousin S, Kayser C, Heuss D, Neundorfer B. Thirty years of multiple system atrophy concept: Review and survey of multiple system atrophy. Fortschritte Neurol Psych 2000; 68: 25–36.
   Web of Science ®Google Scholar
• Lantos PL. Cellular pathology of multiple system atrophy: a review. J Neurol Neurosurg Psychiatr 1994; 57: 129–133.
   PubMed Web of Science ®Google Scholar
• Bower JH, Maraganore DM, Mcdonnell K, Rocca WA. Incidence of progressive supranuclear palsy and multiple system atrophy in Olmstead County, Minnesota, 1976–1990. Neurology 1997; 49: 1284–1288.
   PubMed Web of Science ®Google Scholar
• Wenning GK, Tison F, Ben‐shlomo Y, Daniel SE, Quinn NP. Multiple system atrophy: a review of 203 pathologically proven cases. Move Disord 1997; 12: 133–147.
   PubMed Web of Science ®Google Scholar
• Ben‐shlomo Y, Wenning GK, Tison F, Quinn NP. Survival of patients with pathologically proven multiple system atrophy: A meta analysis. Neurology 1997; 48: 384–393.
   PubMed Web of Science ®Google Scholar
• Sakakibara R, Hattori T, Uchiyama T, Kita K, Asahina M, Suzuki A, Yamamshi T. Urinary dysfunction and orthostatic hypotension in multiple system atrophy: which is the more common and earlier manifestation? J Neurol Neurosurg Psych 2000; 68: 65–69.
   Web of Science ®Google Scholar
• Stefanova N, Bucke P, Duerr S, Wenning GK. Multiple system atrophy: an update. Lancet Neurology 2009; 8: 1172–1178.
   PubMed Web of Science ®Google Scholar
• Ehrt V, Brieger P, Broich K, Marneros A. Psychotic symptoms as initial manifestation of a multiple system atrophy. Fortsch der Neurol Psych 1999; 67: 104–107.
   Web of Science ®Google Scholar
• Gilman S, Low PA, Quinn N, Albanese A, Ben‐schlomo Y, Fowler CJ, Kaufmann H et al. Consensus statement on the diagnosis of multiple system atrophy. J Auto Nerv Syst 1998; 74: 189–192.
   PubMedGoogle Scholar
• Gilman S, Wenning GJK, Low PA, Brooks DJ, Mattias CJ, Trojanowski JQ, Wood NW et al. Second consensus statement on the diagnosis of multiple system atrophy. Neurology 2008; 71: 670–676.
   PubMed Web of Science ®Google Scholar
• Horimoto Y, Aiba I, Yasuda T, Ohkawa Y, Katayama T, Yokokawa Y, Goto A et al. Cerebral atrophy in multiple system atrophy by MRI. J Neurol Sci 2000; 173: 109–112.
   Web of Science ®Google Scholar
• Konogaya M, Sakai M, Matsuoka Y, Konogaya Y, Hashzume Y. Multiple system atrophy with remarkable frontal lobe atrophy. Acta Neuropathol 1999; 97: 423–428.
   Web of Science ®Google Scholar
• Wakabayashi K, Ikeuchi T, Ishikawa A, Takahashi H. Multiple system atrophy with severe involvement of the motor cortical areas and cerebral white matter. J Neurol Sci 1998; 156: 114–117.
   Web of Science ®Google Scholar
• Tsuchiya K, Watabiki S, Sano M, Iobe H, Shiotsu H, Taki K, Hashimoto K. Distribution of cerebellar cortical lesions in multiple system atrophy: a topographic neuropathological study of three autopsy cases in Japan. J Neurol Sci 1998; 155: 80–85.
   Web of Science ®Google Scholar
• Papp MI, Kahn JE, Lantos PL. Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy‐Drager syndrome). J Neurol Sci 1989; 94: 79–100.
   PubMed Web of Science ®Google Scholar
• Dickson DW, Liu WL, Liu WK, Yen SH. Multiple system atrophy: a sporadic synucleinopathy. Brain Pathol 1999; 9: 721–732.
   PubMed Web of Science ®Google Scholar
• Spillantini MG, Crowther RA, Jakes R, Cairns NJ, Lantos PL, Goedert M. Filamentous alpha‐synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies. Neurosci Lett 1998; 251: 205–208.
   PubMed Web of Science ®Google Scholar
• Wenning GK, Quinn NP. Multiple system atrophy. Baillieres Clin Neurol 1997; 6: 187–204.
   PubMedGoogle Scholar
• Ozawa T, Takano H, Onodero O, Kobayashi H, Ikeuchi T, Koide R, Okizumi K et al. No mutation in the entire coding region of the alpha‐synuclein gene in pathologically confirmed cases of multiple system atrophy. Neurosci Lett 1999; 270: 110–112.
   PubMed Web of Science ®Google Scholar
• Hashida H, Goto J, Zhao ND, Takahashi N, Hirai M, Kanazawa I, Sakaki Y. Cloning and mapping of ZNF231, a novel brain‐specific gene encoding neuronal double zinc finger protein whose expression is enhanced in a neurodegenerative disease multiple system atrophy. Genomics 1998; 54: 50–58.
   PubMed Web of Science ®Google Scholar
• Sasaki H, Emi M, Iijima H, Ito N, Sato H, Yabe I, Kato T et al. Copy number loss of (Src homology 2 domain containing) transforming protein 2 (SHC2) gene: discordant loss in monozygotic twins and frequent loss in patients with multiple system atrophy. Mole Brain 2011; 4: 24.
   Web of Science ®Google Scholar
• Cairns NJ, Atkinson PF, Kovacs T, Lees AJ, Daniel SE, Lantos PL. Apolipoprotein E e4 allele frequency in patients with multiple system atrophy. Neurosci Lett 1997; 221: 161–164.
   Web of Science ®Google Scholar
• Ozawa T, Revesz T, Paviour D, Lees AJ, Quinn N, Tada M, Kakita A et al. Difference in MSA phenotype distribution between populations: Genetics or Environment. J Park Dis 2012; 2: 7–18.
   Web of Science ®Google Scholar
• Mathias CJ, Senard JM, Braune S, Watson L, Aragashi A, Keeling JEA, Taylor MD. L‐threo‐dihydroxyphenylserine (L‐threo‐DOPS; droxidopa) in the management of neurogenic orthostatic hypotension: a multi‐national, multi‐center, dose‐ranging study in multiple system atrophy and pure autonomic failure. Clin Auton Res 2001; 11: 235–242.
   PubMed Web of Science ®Google Scholar
• Guzulla J, Benavente MI. Improvements in the symptoms of olivopontocerebellar atrophy with gabapentin. Rev de Neurol 2005; 40: 285–288.
   Web of Science ®Google Scholar
• Price MJ, Feldman RG, Adelberg D, Kayne H. Abnormalities in colour vision and contrast sensitivity in Parkinson's disease. Neurology 1992; 42: 887–890.
   PubMed Web of Science ®Google Scholar
• Buttner T, Kuhn W, Klotz P, Steinberg R, Voss L, Bulgaru D, Przuntek H. Disturbance of colour perception in Parkinson's disease. J Neural Transm 1993; 6: 11–15.
   Web of Science ®Google Scholar
• Sartucci F, Orlandi G, Bonuccelli U, Borghetti D, Murri L, Orsini C, Domenica L et al. Chromatic pattern‐reversal electroretinogram (ChPERG) are spared in multiple system atrophy compared with Parkinson's disease. Neurol Sci 2006; 26: 395–401.
   Web of Science ®Google Scholar
• Tamer C, Melek IM, Dumen T, Oksuz H. Tear film tests in Parkinson's disease patients. Ophthalmology 2005; 112: 1795–1800.
   PubMed Web of Science ®Google Scholar
• Kagohashi M, Okuma Y, Fujishima K, Kitada Y, Mizuno Y. Blepharospasm associated with multiple system atrophy: a case report and review of the literature. Parkinsonism Rel Disord 2004; 10: 169–171.
   PubMed Web of Science ®Google Scholar
• Leon‐sarmiento FE, Bayona‐prieto J, Gomez J. Neurophysiology of blepharospasm and multiple system atrophy: clues to pathophysiology. Parkisonismn Rel Disord 2005; 11: 199–201.
   Web of Science ®Google Scholar
• Rana AO, Kabir A, Dogu O, Patel A, Khondker S. Prevalence of blepharospasm and apraxia of eye opening in patients with parkinsonism, cervical dystonia, and essential tremor. Eur Neurol 2012; 68: 318–321.
   PubMed Web of Science ®Google Scholar
• Tolosa E, Compta Y. Early and prominent blepharospasm in untreated patients with parkinsonism should raise suspicion of progressive supranuclear palsy, multiple system atrophy, or corticobasal degeneration. J Neurol 2005; 253: 7–13.
   Google Scholar
• Valls‐sole J, Valldeoriola F, Tolosa E, Marti MJ. Distinctive abnormalities of facial reflexes in patients with progressive supranuclear palsy. Brain 1997; 120: 1877–1883.
   Web of Science ®Google Scholar
• Rascol O, Sabatini U, Fabre N, Senard JM, Simonett‐amoreau M, Montastruc JL, Clanet M et al. Abnormal vestibulo‐ocular cancellation in multiple system atrophy and progressive supranuclear palsy but not in Parkinson's disease. Move Disord 1995; 10: 163–170.
   Web of Science ®Google Scholar
• Corin MS, Elizan TS, Bender MB. Oculomotor function in patients with Parkinson's disease. J Neurol Sci 1971; 15: 251–265.
   Web of Science ®Google Scholar
• Anderson T, Luxon L, Quinn N, Daniel S, Marsden CD, Bronstein A. Oculomotor function in multiple system atrophy: clinical and laboratory features in 30 patients. Move Disord 2008; 23: 977–984.
   PubMed Web of Science ®Google Scholar
• Bremner F, Smith S. Pupil findings in a consecutive series of 150 patients with generalised autonomic neuropathy. J Neurol Neurosurg Psychiatry 2006; 77: 1163–1168.
   Web of Science ®Google Scholar
• Kuroda M, Fukura H, Saruki N, Yoshikawa D, Morita T, Goto F. Vecuronium dose requirement and pupillary response in a patient with olivopontocerebellar atrophy (OPCA). Can J Anaesth 1998; 45: 979–984.
   Web of Science ®Google Scholar
• Smith SA, Smith SE. Bilateral Horner's syndrome: detection and occurrence. J Neurol Neurosurg Psychiatr 1999; 66: 48–51.
   Web of Science ®Google Scholar
• Delalande I, Hache JC, Forzy G, Bughin M, Benhadjali J, Destee A. Do VEP and spatialtemporal contrast sensitivity help to distinguish idiopathic Parkinson's disease and multiple system atrophy. Move Disord 1998; 13: 446–452.
   Web of Science ®Google Scholar
• van Elst LT, Greenlee MW, Foley JM, Lucking CH. Contrast detection discrimination and adaptation in patients with Parkinson's disease and multiple system atrophy. Brain 1997; 120: 2219–2228.
   Web of Science ®Google Scholar
• Bak TH, Caine D, Hearn VC, Hodges JR. Visuospatial functions in atypical parkinsonian syndromes. J Neurol Neurosurg Psychiatry 2006; 77: 454–456.
   PubMed Web of Science ®Google Scholar
• Abele M, Schulz JB, Burk K, Topka H, Dichgans J, Klockgetter T. Evoked potentials in multiple system atrophy (MSA). Acta Neurol Scand 2000; 101: 111–115.
   Web of Science ®Google Scholar
• Wang LH, Kuroiwa Y, Kamitani T, Li M, Takahashi T, Suzuki Y, Shimamura M, Hasegawa O. Visual event‐related potentials in progressive supranuclear palsy, corticobasal degeneration, striatonigral degeneration and Parkinsons's disease. J Neurol 2000; 247: 356–363.
   Web of Science ®Google Scholar
• Koga Y, Nagata K, Hirata K. Hypothesis on the P300 generators based on visual P300 results in neurological disorders. Brain Topog Today Int Cong Series 1997; 1147: 354–357.
   Google Scholar
• Kamitani T, Kuroiwa T, Wang LH, Li M, Suzuki Y, Takahashi T, Ikegami T et al. Visual event‐related potential changes in two subtypes of multiple system atrophy, MSA‐C and MSA‐P. J Neurol 2002; 249: 975–982.
   Web of Science ®Google Scholar
• Kamitani T, Kuroiwa Y. Visual event‐related potential changes in multiple system atrophy: delayed N2 latency in selective attention to a color task. Parkinsonism Relat Disord 2009; 15: 36–40.
   Web of Science ®Google Scholar
• Ghorayeb I, Biolac B, Tison F. Sleep disorders in multiple system atrophy. J Neural Transm 2005; 112: 1669–1675.
   Web of Science ®Google Scholar
• Vetrugno R, Alessandria M, D'angelo R, Plazzi G, Provini F, Cortelli P, Montagno P. Status dissociatus evolving from REM sleep behavioural disorder in multiple system atrohy. Sleep Med 2009; 10: 247–252.
   Web of Science ®Google Scholar
• Turner RS. Idiopathic rapid eye movement sleep behaviour disorder is a harbinger of dementia with Lewy bodies. J Ger Psych Neurol 2002; 15: 195–199.
   Web of Science ®Google Scholar
• Sachin S, Shukla G, Goyal V, Singh S, Aggrawal V, Guresh‐kumar, Behari M. Clinical speech impairment in Parkinson's disease, progressive supranuclear palsy, and multiple system atrophy. Neurol India 2008; 56: 122–126.
   Web of Science ®Google Scholar
• Bertram K, Williams DR. Visual hallucinations in the differential diagnosis of parkinsonism. J Neurol Neurosurg Psychiatry 2012, 83, 448–452.
   PubMed Web of Science ®Google Scholar
• Barnes CS, Yan J, Wilmot GR. A negative electroretinogram (ERG) in a case of probable multiple system atrophy (MSA). Doc Ophthalmol 2009; 118: 247–256.
   PubMed Web of Science ®Google Scholar
• Cronin‐golomb A, Corkin S, Rizzo JF, Cohen J, Growden JH, Banks KS. Visual dysfunction in Alzheimer's disease: relation to normal ageing. Ann Neurol 1991; 29: 41–52.
   PubMed Web of Science ®Google Scholar
• Kiyosawa M, Bosley TM, Chawluk J, Jamieson D, Schatz NJ, Savino PJ, Sergott RC et al. Alzheimer's disease with prominent visual symptoms; clinical and metabolic evaluation. Ophthalmology 1989; 96: 1077–1085.
   PubMed Web of Science ®Google Scholar
• Shibasaki H, Tsuji S, Kuroiwa Y. Oculomotor abnormalities in Parkinson's disease. Arch Neurol 1979; 36: 360–364.
   PubMed Web of Science ®Google Scholar
• Neetens A, van den Ende P, Smet H, Martin JJ. Disturbed vertical optokinetic nystagmus: possible sign of striatonigral pathway involvement. J Neuroophthalmol 1991; 11: 141–149.
   Web of Science ®Google Scholar
• Altiparmak UE, Eggenberger E, Coleman A, Condon K. The ratio of square wave jerk rates to blink rate distinguishes progressive supranuclear palsy from Parkinson's disease. J Neuroophthalmol 2006; 26: 257–259.
   PubMed Web of Science ®Google Scholar
• Bulens C, Meerwaldt JD, Van der wildt GJ, Van deursen JBP. Effect of levodopa treatment on contrast sensitivity in Parkinson's disease. Ann Neurol 1987; 22: 365–369.
   PubMed Web of Science ®Google Scholar
• Hutton JT, Morris JL, Elias JW. Levodopa improves spatial contrast sensitivity in Parkinson's disease. Arch Neurol 1993; 50: 721–724.
   PubMedGoogle Scholar
• Langheinrich T, van Elst LT, Lagreze WA, Bach M, Lucking CH, Greenlee MW. Visual contrast response functions in Parkinson's disease: evidence from electroretinogram, visually evoked potentials and psychophysics. Clin Neurophysiol 2000; 111: 66–74.
   PubMed Web of Science ®Google Scholar
• Sierra‐hidalgo F, de Pablo‐fernández E, Martín AHS, Corresa‐callero E, Herreros‐rodríguez J, Romero‐muñoz JP, Martín‐gil L. Clinical and imaging features of the room tilt illusion. J Neurol 2012; 259: 2555–2564.
   Web of Science ®Google Scholar
• Schmeichel AM, Buchhalter LC, Low PA, Parisi JE, Boeve BW, Sandroni P, Benarroch EE. Mesopontine cholinergic neuron involvement in Lewy body dementia and multiple system atrophy. Neurology 2008; 70: 368–373.
   PubMed Web of Science ®Google Scholar
• Kurata T, Kametaka S, Ohta Y, Morimoto N, Deguci S, Deguchi K, Ikeda Y et al. PSP as distinguished from CBD, MSA‐P and PD by clinical and imaging differences at early stage. Intern Med 2011; 50: 2775–2781.
   PubMed Web of Science ®Google Scholar
• Zhang KZ, Zeng YY, Song CJ, Fu Y, Wan Q. The comparison of clonidine, arginine and both combined: a growth hormone stimulation test to differentiate multiple system atrophy from idiopathioc Parkinson's disease. J Neurol 2010; 257: 1486–1491.
   Web of Science ®Google Scholar
• Kumbler E, Kornhuber M. Delusional parasitosis in multiple system atrophy. Nervenarzt 2002; 73: 380–383.
   Web of Science ®Google Scholar
• Pierrot‐deseilligny C, Pivauld‐pechoux S. Contribution of oculomotor explotation for the etiological diagnosis of parkinsonian syndromes. Rev Neurol 2003; 159: S75‐S81.
   Google Scholar
• Rottack KG, Riley DE, Discenna AO, Zivotofsky AZ, Leigh RJ. Dynamic properties of horizontal and vertical eye movements in parkinsonian syndromes. Ann Neurol 1996; 39: 368–377.
   Web of Science ®Google Scholar
• Pinnock RA, Mcgivern RC, Forbes R, Gibson JM. An exploration of ocular fixation in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy. J Neurol 2010; 257: 533–539.
   Web of Science ®Google Scholar
• Pinkhardt EH, Kassubek J, Sussmuth S, Ludolph AC, Becker W, Jurgens R. Comparison of smooth pursuit eye movement deficits in multiple system atrophy and Parkinson's disease. J Neurol 2009; 256: 1438–1446.
   Web of Science ®Google Scholar
• Fletcher WA. Eye signs in patients with parkinsonism: do they predict the development of multiple system atrophy. Nature Clin Prac 2008; 4: 540–541.
   Google Scholar
• Salazar G, Casas E, Oliveras D, Rando A, Sergio P. Ocular‐jaw synkinesia in normal, Parkinson's disease, and multiple system atrophy subjects: Clinical and electrophysiological findings. Clin Neurophysiol 2010; 121: 94–97.
   Web of Science ®Google Scholar
• Koch JM, Datta G, Makdoom S, Grossberg GT. Unmet visual needs of Alzheimer's disease patients in long‐term care facilities. J Am Med Dir Assoc 2005; 6: 233–237.
   PubMedGoogle Scholar
• Naylor RJ. The ocular effects of parkinsonism and its treatment. Optom Pract 2005; 6: 19–31.
   Google Scholar
• Mccarty CA, Fu CL, Taylor HR. Predictors of falls in the Melbourne visual impairment project. Aust NZ J Pub Health 2002; 26: 116–119.
   PubMed Web of Science ®Google Scholar
• West SK, Munoz B, Rubin GS, Schein OD, Bandeen‐roche K, Zeger S, German PS et al. Function and visual impairment in a population‐based study of older adults. The SEE project. Salisbury Eye Evaluation. Invest Ophthalmol Vis Sci 1997; 38: 72–82.
   PubMed Web of Science ®Google Scholar
• Vu HT, Keeffe JE, Mccarty CA, Taylor HR. Impact of unilateral and bilateral vision loss on quality of life. Br J Ophthalmol 2005; 89: 360–363.
   PubMed Web of Science ®Google Scholar